TITLE

Radiofrequency Transurethral Hyperthermia and Complete Androgen Blockade: A Nonsurgical Approach to Treating Prostate Cancer

AUTHOR(S)
Douwes, Friedrich R.; Lieberman, Shari
PUB. DATE
June 2002
SOURCE
Alternative & Complementary Therapies;Jun2002, Vol. 8 Issue 3, p149
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
83564104

 

Related Articles

  • Protect Your Prostate Part I. Colgan, Michael // Colgan Chronicles;2001, Vol. 4 Issue 5, p4 

    Relates developments in the prevention and treatment of prostate cancer. High rate of side-effects produced by transurethral resection of the prostate; Less invasive surgeries to treat prostate cancer; Drugs most prescribed for controlling prostate cancer including androgen-blockers,...

  • Prostate Cancer.  // Current Medical Literature: Urology;2009, Vol. 15 Issue 4, p100 

    The article discusses research on prostate cancer conducted in 2009. It references the studies "Pathological Characteristics of Prostate Cancer in Elderly Men," by C. Y. Wang et al published in "Journal of Urology," "Thirty-Day Mortality After Transurethral Resection of the Prostate in Patients...

  • Microwave treatment for the enlarged prostate (benign prostatic hyperplasia).  // HealthFacts;Jul93, Vol. 18 Issue 170, p3 

    Reports on the use of microwave treatment for the enlarged prostate. Transurethral prostatectomy; Microwave hyperthermia; Transurethral resection of the prostate.

  • Management of androgen-ablation refractory prostate cancer. Role for somatostatin analogues? Rohd-Thomsen, Suleika J.; van der Plaat, Lia; Zylicz, Zbigniew // Advances in Palliative Medicine;2010, Vol. 9 Issue 4, p145 

    Patients with metastasised prostate cancer survive longer with anti-androgen therapy but eventually all progress into the androgen-ablation refractory (AAR) stage and die. There are only few effective strategies to treat patients with AAR cancers and they include even more effective androgen...

  • Chapter 5: Treating Benign Prostatic Hyperplasia. Barrett, David M. // Mayo Clinic on Prostate Health (2000);2000, p41 

    There are various ways of treating benign prostatic hyperplasia. It includes medication, surgery, heat therapy, and nonsurgical procedures. Alpha-blockers and finasteride are the two types of medications used. Surgical methods include transurethral resection of the prostate and open...

  • Antiandrogen plus LHRHa efficacious in advanced PCa. Nierengarten, Mary Beth // Urology Times;9/1/2005, Vol. 33 Issue 11, p10 

    Reports on the therapeutic benefits of adding the nonsteroidal antiandrogen bicalutamide (Casodex) to a luteinizing hormone-releasing hormone agonist (LHRHa) in treating advanced prostate cancer (PCa) by researchers from Japan. Indications showing the effectiveness of maximal androgen blockade...

  • Hormone therapy: A 'third choice' for localized PCa? Tennant, Scott // Urology Times;Oct2001, Vol. 29 Issue 10, p6 

    Reports on hormone therapy for prostate cancer patients in advanced stages in Los Angeles. Treatment for localized cancer by androgen blockade; Efficacy of triple androgen blockade for management of patients; Emphasis on the effectivity of hormonal treatment at the earliest stage.

  • Androgen-Independent Prostate Cancer: Potential Role of Androgen and ErbB Receptor Signal Transduction Crosstalk.  // Neoplasia;Mar/Apr2003, Vol. 5 Issue 2, p99 

    Summarizes evidence of the functionality of androgen receptor (AR) signalling in prostate cancer under conditions of maximal androgen blockade. Information on prostate cancer; Background on AR; role of the phsophorylation of phosphatidylinositol at the D3 position in cell survival.

  • Hitting below the belt. Halvorsen, Richard // Director;May98, Vol. 51 Issue 10, p91 

    Differentiates cancer of the prostate from benign prostatic hyperplasia (BPH). Procedure involved in the transurethral resection of the prostate (TURP) to treat BOH; Alternatives to BPH; Debate over treatment of and screening for prostate cancer.

  • Optimal Management of Recurrent Prostate Cancer in Older Patients. Kessler, Elizabeth R.; Flaig, Thomas W. // Drugs & Aging;2012, Vol. 29 Issue 11, p871 

    With a large, aging population in the USA and continued prolongation of life expectancy, treatment of cancer in the elderly will continue to be of importance. The most common cancer in men is prostate cancer, which is most often diagnosed in those over the age of 65 years. Initial therapies for...

Share

Other Topics